Atlas Trials

Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade

Clinical trial NCT03493932 · COMPLETED

Trial details

NCT number
NCT03493932
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Glioblastoma
Start date
2018-09-24
Primary completion
2023-04-21
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.